Literature DB >> 9002678

Myosin VIIA gene: heterogeneity of the mutations responsible for Usher syndrome type IB.

G Lévy1, F Levi-Acobas, S Blanchard, S Gerber, D Larget-Piet, V Chenal, X Z Liu, V Newton, K P Steel, S D Brown, A Munnich, J Kaplan, C Petit, D Weil.   

Abstract

Usher syndrome is recognized as the most frequent cause of hereditary deaf-blindness. Usher syndrome type I (USH1), the most severe form of the disease, is characterized by profound congenital sensorineural deafness, constant vestibular dysfunction, and retinitis pigmentosa of prepubertal onset. This form is genetically heterogeneous and five loci (USH1A-E) have been mapped thusfar. However, only the gene responsible for USH1 B (which accounts for approximately 75% of USH1 cases) has been characterized. It encodes a long-tailed unconventional myosin, myosin VIIA, with a predicted 2215 amino acid sequence. Primers covering the complete myosin VIIA coding sequence as well as the 3' non coding sequence were designed, allowing direct sequence analysis of each of the 48 coding exons and flanking splice sites in seven patients affected by USH1. Four novel mutations were thereby identified. The possibility should now be considered of a sequence-based prenatal diagnosis in some of the families affected by this very severe form of Usher syndrome.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9002678     DOI: 10.1093/hmg/6.1.111

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  28 in total

Review 1.  Towards a molecular understanding of Drosophila hearing.

Authors:  Jason C Caldwell; Daniel F Eberl
Journal:  J Neurobiol       Date:  2002-11-05

Review 2.  AT-AC pre-mRNA splicing mechanisms and conservation of minor introns in voltage-gated ion channel genes.

Authors:  Q Wu; A R Krainer
Journal:  Mol Cell Biol       Date:  1999-05       Impact factor: 4.272

3.  MYO7A mutation screening in Usher syndrome type I patients from diverse origins.

Authors:  T Jaijo; E Aller; M Beneyto; C Najera; C Graziano; D Turchetti; M Seri; C Ayuso; M Baiget; F Moreno; C Morera; H Perez-Garrigues; J M Millan
Journal:  J Med Genet       Date:  2007-03       Impact factor: 6.318

4.  Unconventional myosins at the crossroad of signal transduction and cytoskeleton remodeling.

Authors:  T Soldati; E C Schwarz; H Geissler
Journal:  Protoplasma       Date:  1999       Impact factor: 3.356

Review 5.  Unconventional myosins, the basis for deafness in mouse and man.

Authors:  T Hasson
Journal:  Am J Hum Genet       Date:  1997-10       Impact factor: 11.025

6.  Characterization of Usher syndrome type I gene mutations in an Usher syndrome patient population.

Authors:  Xiao Mei Ouyang; Denise Yan; Li Lin Du; J Fielding Hejtmancik; Samuel G Jacobson; Walter E Nance; An Ren Li; Simon Angeli; Muriel Kaiser; Valerie Newton; Steve D M Brown; Thomas Balkany; Xue Zhong Liu
Journal:  Hum Genet       Date:  2005-01-20       Impact factor: 4.132

7.  Functional characterization of the human myosin-7a motor domain.

Authors:  Sarah M Heissler; Dietmar J Manstein
Journal:  Cell Mol Life Sci       Date:  2011-06-18       Impact factor: 9.261

8.  A Myo7a mutation cosegregates with stereocilia defects and low-frequency hearing impairment.

Authors:  Charlotte R Rhodes; Ronna Hertzano; Helmut Fuchs; Rachel E Bell; Martin Hrabé de Angelis; Karen P Steel; Karen B Avraham
Journal:  Mamm Genome       Date:  2004-09       Impact factor: 2.957

9.  Deafness and retinal degeneration in a novel USH1C knock-in mouse model.

Authors:  Jennifer J Lentz; William C Gordon; Hamilton E Farris; Glen H MacDonald; Dale E Cunningham; Carol A Robbins; Bruce L Tempel; Nicolas G Bazan; Edwin W Rubel; Elizabeth C Oesterle; Bronya J Keats
Journal:  Dev Neurobiol       Date:  2010-03       Impact factor: 3.964

10.  Linkage analysis in Usher syndrome type I (USH1) families from Spain.

Authors:  C Espinós; C Nájera; J M Millán; C Ayuso; M Baiget; H Pérez-Garrigues; O Rodrigo; C Vilela; M Beneyto
Journal:  J Med Genet       Date:  1998-05       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.